Melvin Sharoky M.D., Director at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 20,000 shares at $27.39 ($549K) on 2010-04-15, disclosed to the SEC on 2010-04-16.
Open-market sale of $549k PRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.39 | 3,290 | $90K | 16.4% |
| 2 | $27.40 | 2,500 | $69K | 12.5% |
| 3 | $27.43 | 100 | $3K | 0.5% |
| 4 | $27.44 | 300 | $8K | 1.5% |
| 5 | $27.46 | 600 | $16K | 3.0% |
| 6 | $27.47 | 1,400 |
| $38K |
| 7.0% |
| 7 | $27.48 | 900 | $25K | 4.5% |
| 8 | $27.49 | 300 | $8K | 1.5% |
| 9 | $27.50 | 10,610 | $292K | 53.1% |
| Total | $27.46 avg | 20,000 | $549K | 100% |
| Filing → |
| INSM | SELL | 2025-09-15 | $2.9M | — | Filing → |
| INSM | SELL | 2025-08-21 | $1.3M | — | Filing → |
| INSM | SELL | 2025-08-14 | $1.2M | — | Filing → |